
ChromaDex Corporation
CEO
Frank Louis Jaksch Jr.
IPO Date
2008-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 492,278 |
| $5.48 |
| 13 Dec 2024 | Jaksch Frank L Jr | director | M-Exempt | Acquired | 50,001 | $3.66 |
| 13 Dec 2024 | Jaksch Frank L Jr | director | S-Sale | Disposed | 37,161 | $6.19 |
| 13 Dec 2024 | Jaksch Frank L Jr | director | M-Exempt | Disposed | 50,001 | $3.66 |
| 26 Aug 2024 | Patrick Kristin | director | M-Exempt | Acquired | 20,000 | $1.67 |
| 26 Aug 2024 | Patrick Kristin | director | M-Exempt | Disposed | 3,000 | $1.64 |
| 26 Aug 2024 | Patrick Kristin | director | M-Exempt | Acquired | 3,000 | $1.64 |
| 26 Aug 2024 | Patrick Kristin | director | M-Exempt | Disposed | 20,000 | $1.67 |
| 26 Aug 2024 | Patrick Kristin | director | S-Sale | Disposed | 23,000 | $3.57 |